Teaser video

Making BREAKTHROUGH DISCOVERIES a reality.

A life science company

Four decades dedicated to enabling life science labs of the future, where innovative technology and novel research converge.

State of the art automated 3D imaging workcell

State-of-the-art automated 3D imaging workcell

The Organoid Innovation Center at Molecular Devices combines cutting-edge technologies with novel research methods to address key challenges of scaling complex 3D biological models.

The collaborative space brings customers and researchers into the lab to test automated workflows for organoid culturing and screening, with guidance from in-house scientists.

Learn more
3D Biology

3D Biology

3D biology is an emerging field revolutionizing the way scientists screen new drugs and understand diseases.

3D cell models like organoids have a unique makeup that offers a step-change in predicting human responses to novel treatments. Their increased physiological relevance leads to more accurate indications of a therapeutic’s efficacy in the pre-clinical phase. This allows for the weeding out of toxic, ineffective compounds to make space for those with healing power earlier in the drug discovery process.

Learn more
Cell Engineering

Cell Engineering

The addition of our colony picker platform expands the Center’s state-of-the-art methods and technologies to include automated workflows for synthetic biology, antibody discovery, and cell line development.

And, with the recent launch of CloneSelect® Imager FL with multi-channel fluorescence for day zero monoclonality verification and confirmation of CRISPR edits, provides a wide range of cell and gene therapy applications.

Learn more
Lab Automation

Lab Automation

From our PhD-level technical support staff to our expert-trained and certified field service engineers, our Global Professional Services teams guide scientists through customized automation solutions that are uniquely designed to meet the specific needs of your assay, method, or protocol.

We offer a highly consultative approach when automating high-throughput plate-based, cellular screening, and clone screening assays with customized, automated labware, robotic solutions, and intuitive software.

Learn more
 Proprietary patient-derived Organoid Technology

Proprietary patient-derived organoid technology

“Molecular Devices has the capability, reputation, reach, and resources to ensure that the Cellesce technology can be further developed, and used to its full potential. We’re excited to bring our domain expertise and intellectual property to Molecular Devices, together maximizing impact for customers in revolutionizing drug discovery and unlocking the full potential of human-relevant 3D biology research.” 


– Vicky Marsh-Durban, CEO of Cellesce

Learn more

We empower scientists to advance discovery

Automated, end-to-end solutions span research disciplines to help scientists discover, scale, and industrialize biology.

We’re scientists supporting scientists

We empower scientists to advance discovery, driving earlier diagnoses and safer therapeutics for patients.

3D Human Organoid

3D Biology: The paradigm shift in next-gen drug discovery

In the midst of an evolving drug discovery paradigm, researchers worldwide are transitioning their compound screens away from 2D cell cultures and animal models to more complex, human-relevant 3D systems like organoids. Experience our interactive infographic as it takes you deeper into why the industry is embracing this next generation of drug discovery and the innovations supporting scientists in their 3D biology journey.

Learn more
Drug Discovery & Development

Drug Discovery & Development

The drug discovery landscape is shifting, with more scientists centering cell line development, disease models, and high-throughput screening methods around physiologically-relevant 3D cell models. 

The reason for this is clear: Using cellular model systems in research that closely mimic patient disease states or human organs can bring life-saving therapeutics to market – faster.

Learn more
3D Cell Models

3D Cell Models

With our automated 3D cell culture and bioimaging screening solutions, we are helping reshape the future of drug discovery. Supported by our technology and organoid development protocols, researchers can now advance and scale screening methods for physiologically-relevant 3D models that more closely mimic patient disease states and human organs, leading to faster drug development and approval.

Learn more
Cell Line Development

Cell Line Development

Our cell line development customers accelerate time to market for life saving monoclonal antibodies (mAbs) and genomic medicine, as well as perform groundbreaking research in cell and gene therapies, genetic engineering, personalized and precision medicine, synthetic biology, RNA and DNA-based vaccines, and so much more – made possible by our innovative technology and rich expertise.

Learn more
Drug Screening

Drug Screening

For every drug that makes it to the finish line, another nine don’t succeed. This alarming failure rate can be traced to reliance on 2D cell cultures that don’t closely mimic complex human biology, often leading to inaccurate predictions of a drug’s potential and extended drug development timelines.

A critical step in the drug discovery process, drug screening and toxicity assessment uncovers effects of potentially life-saving compounds. Scale drug discovery research with a high-throughput screening solution.

Learn more